Intense training, poor sleep, or even dieting for too long can leave you feeling run-down
They target the underlying biology of hunger, with weight loss as the main goal rather than a side effect
Dose: 7.5mg subcutaneous injection weekly Expected side effects: Significant nausea (70-80% of users), possible vomiting (25-35%), food aversions, fatigue Expected weight loss: 6-10 pounds during this phase (14-23 pounds total) Critical actions: Emergency food protocols, aggressive hydration, consider anti-nausea medications This phase separates successful accelerated titration from abandonment
Critically, GIP receptor activation in adipose (fat) tissue appears to enhance fat mobilization and energy expenditure beyond what GLP-1 can do alone which helps explain tirzepatides superior weight loss outcomes in clinical trials
Garcia-Alloza, M
In contrast to bariatric surgery, which addresses root causes and delivers lasting results, GLP-1 drugs provide only temporary solutions, potentially leading to medication reliance